187 related articles for article (PubMed ID: 12201957)
21. Functional reconstitution of oxidase activity in X-linked chronic granulomatous disease by retrovirus-mediated gene transfer.
Zentilin L; Tafuro S; Grassi G; Garcia R; Ventura A; Baralle F; Falaschi A; Giacca M
Exp Cell Res; 1996 Jun; 225(2):257-67. PubMed ID: 8660913
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of vinorelbine plus granulocyte colony-stimulation factor for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma.
Samaras P; Pfrommer S; Seifert B; Petrausch U; Mischo A; Schmidt A; Schanz U; Nair G; Bargetzi M; Taverna C; Stupp R; Stenner-Liewen F; Renner C
Biol Blood Marrow Transplant; 2015 Jan; 21(1):74-80. PubMed ID: 25278456
[TBL] [Abstract][Full Text] [Related]
23. Mobilization of peripheral blood stem cells with paclitaxel and rhG-CSF in high-risk breast cancer patients.
Meehan KR; Slack R; Gehan E; Herscowitz HB; Areman EM; Ebadi M; Cairo MS; Lippman ME
J Hematother Stem Cell Res; 2002 Apr; 11(2):415-21. PubMed ID: 11983113
[TBL] [Abstract][Full Text] [Related]
24. Lentivirus-mediated gene transfer of gp91phox corrects chronic granulomatous disease (CGD) phenotype in human X-CGD cells.
Saulnier SO; Steinhoff D; Dinauer MC; Zufferey R; Trono D; Seger RA; Hossle JP
J Gene Med; 2000; 2(5):317-25. PubMed ID: 11045425
[TBL] [Abstract][Full Text] [Related]
25. Gene therapy of chronic granulomatous disease.
Grez M; Becker S; Saulnier S; Knöss H; Ott MG; Maurer A; Dinauer MC; Hoelzer D; Seger R; Hossle JP
Bone Marrow Transplant; 2000 May; 25 Suppl 2():S99-104. PubMed ID: 10933200
[TBL] [Abstract][Full Text] [Related]
26. Cytokine-mobilized peripheral blood CD34+Thy-1+Lin- human hematopoietic stem cells as target cells for transplantation-based gene therapy.
Chen BP; Fraser C; Reading C; Murray L; Uchida N; Galy A; Sasaki D; Tricot G; Jagannath S; Barlogie B
Leukemia; 1995 Oct; 9 Suppl 1():S17-25. PubMed ID: 7475307
[TBL] [Abstract][Full Text] [Related]
27. Successful hematopoietic stem cell transplantation in 2 children with X-linked chronic granulomatous disease from their unaffected HLA-identical siblings selected using preimplantation genetic diagnosis combined with HLA typing.
Goussetis E; Konialis CP; Peristeri I; Kitra V; Dimopoulou M; Petropoulou T; Vessalas G; Papassavas A; Tzanoudaki M; Kokkali G; Petrakou E; Spiropoulos A; Pangalos CG; Pantos K; Graphakos S
Biol Blood Marrow Transplant; 2010 Mar; 16(3):344-9. PubMed ID: 19835970
[TBL] [Abstract][Full Text] [Related]
28. Gamma-glutamylcysteine synthetase-based selection strategy for gene therapy of chronic granulomatous disease and graft-vs.-host disease.
Rappa G; Anzanello F; Alexeyev M; Fodstad O; Lorico A
Eur J Haematol; 2007 May; 78(5):440-8. PubMed ID: 17331133
[TBL] [Abstract][Full Text] [Related]
29. Hyperinflammation in patients with chronic granulomatous disease leads to impairment of hematopoietic stem cell functions.
Weisser M; Demel UM; Stein S; Chen-Wichmann L; Touzot F; Santilli G; Sujer S; Brendel C; Siler U; Cavazzana M; Thrasher AJ; Reichenbach J; Essers MAG; Schwäble J; Grez M
J Allergy Clin Immunol; 2016 Jul; 138(1):219-228.e9. PubMed ID: 26853280
[TBL] [Abstract][Full Text] [Related]
30. Mobilization characteristics and strategies to improve hematopoietic progenitor cell mobilization and collection in patients with chronic granulomatous disease and severe combined immunodeficiency.
Panch SR; Yau YY; Kang EM; De Ravin SS; Malech HL; Leitman SF
Transfusion; 2015 Feb; 55(2):265-74. PubMed ID: 25143186
[TBL] [Abstract][Full Text] [Related]
31. Simian immunodeficiency virus lentivector corrects human X-linked chronic granulomatous disease in the NOD/SCID mouse xenograft.
Naumann N; De Ravin SS; Choi U; Moayeri M; Whiting-Theobald N; Linton GF; Ikeda Y; Malech HL
Gene Ther; 2007 Nov; 14(21):1513-24. PubMed ID: 17728796
[TBL] [Abstract][Full Text] [Related]
32. CD34+ peripheral blood progenitors as a target for genetic correction of the two flavocytochrome b558 defective forms of chronic granulomatous disease.
Li F; Linton GF; Sekhsaria S; Whiting-Theobald N; Katkin JP; Gallin JI; Malech HL
Blood; 1994 Jul; 84(1):53-8. PubMed ID: 7517218
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with successful mobilization of progenitor hematopoietic stem cells among patients with lymphoid malignancies.
Ameen RM; Alshemmari SH; Alqallaf D
Clin Lymphoma Myeloma; 2008 Apr; 8(2):106-10. PubMed ID: 18501104
[TBL] [Abstract][Full Text] [Related]
34. Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation.
Singhal S; Powles R; Kulkarni S; Treleaven J; Sirohi B; Millar B; Shepherd V; Saso R; Rowland A; Long S; Cabral S; Horton C; Mehta J
Bone Marrow Transplant; 2000 Mar; 25(5):501-5. PubMed ID: 10713626
[TBL] [Abstract][Full Text] [Related]
35. [The effect of matrix metalloproteinase-9 in granulocyte colony stimulation factor-induced stem cell mobilization].
Jin FY; Qiu LG; Li QC; Meng HX; Wang YF; Yu Z; Li Q; Han JL
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2966-70. PubMed ID: 17288807
[TBL] [Abstract][Full Text] [Related]
36. Characterization of peripheral blood progenitor cells mobilized by nartograstim (N-terminal replaced granulocyte colony-stimulating factor) in normal volunteers.
Maruyama K; Tsuji K; Tanaka R; Yamada K; Kodera Y; Nakahata T
Bone Marrow Transplant; 1998 Aug; 22(4):313-20. PubMed ID: 9722064
[TBL] [Abstract][Full Text] [Related]
37. Gene therapy for chronic granulomatous disease.
Kume A; Dinauer MC
J Lab Clin Med; 2000 Feb; 135(2):122-8. PubMed ID: 10695656
[TBL] [Abstract][Full Text] [Related]
38. Gene therapy of chronic granulomatous disease (CGD) by gene transfer into hematopoietic stem cells.
Zentilin L; Tafuro S; Serra C; Falaschi A; Giacca M
Ann Ist Super Sanita; 1998; 34(4):447-55. PubMed ID: 10234875
[TBL] [Abstract][Full Text] [Related]
39. [Optimization of mobilization regimes of blood hemopoietic stem cells in patients with multiple myeloma].
Pokrovskaia OS; Mendeleeva LP; Urnova ES; Gaponova TV; Gribanova EO; Alekseeva IV; Drokov MIu; Kalinin NN; Gretsov EM; Kliasova GA; Savchenko VG
Ter Arkh; 2011; 83(7):50-7. PubMed ID: 21894752
[TBL] [Abstract][Full Text] [Related]
40. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease.
Gaia S; Smedile A; Omedè P; Olivero A; Sanavio F; Balzola F; Ottobrelli A; Abate ML; Marzano A; Rizzetto M; Tarella C
J Hepatol; 2006 Jul; 45(1):13-9. PubMed ID: 16635534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
